Michael Deininger Laboratory

The Deininger lab’s expertise focuses on translational research in leukemia, specifically the biology of myeloproliferative neoplasms and the development of molecular targeted therapies. We are especially interested in developing novel, anti-neoplastic targeted therapies in myeloid leukemia, as well as understanding the molecular mechanisms of cancer stem cell persistence and leukemia drug resistance.

Our lab orchestrates a multidisciplinary cancer research program, straddling genetics, biochemistry, molecular biology, pharmacology and biomedical engineering. We are proud of our vibrant team of scientists who strive to improve the diagnosis, deep analysis and therapeutics of myeloid leukemia.